| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2543441 | Journal of the American Pharmacists Association | 2014 | 9 Pages |
Abstract
Patients newly diagnosed with diabetes face a substantially increased burden of medications used to control diabetes and other comorbidities. This study shows an increased focus on cardiovascular disease risk factor control after diagnosis of diabetes. However, total drug burden may be slightly decreasing over time.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Julie A. (Research Scientist), Marsha A. (Senior Investigator), Wendy (Data Consultant), Stanley (Head of Biostatistics and Investigator), Glenn K. (Data Specialist), Emily B. (Investigator), Jodi B. (Associate Professor),